Display options
Cite
Moossavi S, Besharat S, Sharafkhah M, et al. Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron. Middle East J Dig Dis. 2016;8(2):122-30doi: 10.15171/mejdd.2016.17.
Moossavi, S., Besharat, S., Sharafkhah, M., Ghanbari, R., Sharifi, A., Rezanejad, P., Pourshams, A., Poustchi, H., & Mohamadkhani, A. (2016). Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron. Middle East journal of digestive diseases, 8(2), 122-30. https://doi.org/10.15171/mejdd.2016.17
Moossavi, Shirin, et al. "Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron." Middle East journal of digestive diseases vol. 8,2 (2016): 122-30. doi: https://doi.org/10.15171/mejdd.2016.17
Moossavi S, Besharat S, Sharafkhah M, Ghanbari R, Sharifi A, Rezanejad P, Pourshams A, Poustchi H, Mohamadkhani A. Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron. Middle East J Dig Dis. 2016 Apr;8(2):122-30. doi: 10.15171/mejdd.2016.17. PMID: 27252819; PMCID: PMC4885611.
Copy Download .nbib Format: NLM
Share it on

Middle East J Dig Dis. 2016 Apr;8(2):122-30. doi: 10.15171/mejdd.2016.17.

Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron.

Middle East journal of digestive diseases

Shirin Moossavi, Sima Besharat, Maryam Sharafkhah, Reza Ghanbari, Amrollah Sharifi, Parisa Rezanejad, Akram Pourshams, Hossein Poustchi, Ashraf Mohamadkhani

Affiliations

  1. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  2. Department of Clinical nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 27252819 PMCID: PMC4885611 DOI: 10.15171/mejdd.2016.17

Abstract

BACKGROUND Oxidative stress has a major pathogenic role for liver damage following chronic hepatitis B. Glutathione peroxidase (Gpx) is necessary in oxidative state mechanism that is generally down-regulated by Hepatitis B virus (HBV) infection. On the other hand, disorders of iron homeostasis have been found out in HBV infected patients. Therefore, the objective of this study was to assess the interplay of Gpx and serum iron on clinical and virological features of patients with chronic HBV infection. METHODS One hundred and fifty adult, treatment-naïve, patients with chronic hepatitis B were randomly designated from an ongoing cohort of patients with HBV. Plasma Gpx1 concentration and HBV DNA quantity were measured. Liver stiffness was measured by transient elastography. RESULTS Serum iron had a positive association with HBV DNA count in the total population. Serum iron was not associated with liver stiffness. However, HBV DNA was significantly associated with liver stiffness only in male patients. Serum Gpx was inversely associated with liver stiffness. Serum iron and Gpx had indirect effects on liver stiffness via HBV DNA count. We observed dissimilar effects of serum iron on HBV DNA and Gpx on liver stiffness in male and female patients. CONCLUSION We identified interplay of serum iron and Gpx1 in relation to level of liver fibrosis in patients with chronic hepatitis B. Our results propose that oxidative stress and serum iron are differentially implicated in the progression of chronic hepatitis B in male and female patients.

Keywords: Glutathione peroxidase (Gpx); HBV DNA; Hepatitis B; Iron; Liver Stiffness

References

  1. Hepat Mon. 2015 Feb 21;15(2):e23875 - PubMed
  2. Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):803-16 - PubMed
  3. Nucleic Acids Res. 2014 Jan;42(Database issue):D926-32 - PubMed
  4. J Gen Virol. 2014 May;95(Pt 5):991-1004 - PubMed
  5. J Gastroenterol Hepatol. 2007 Nov;22(11):1886-93 - PubMed
  6. Hepatol Res. 2007 Mar;37(3):172-8 - PubMed
  7. Hepatogastroenterology. 2013 Oct;60(127):1736-41 - PubMed
  8. Middle East J Dig Dis. 2015 Jan;7(1):5-13 - PubMed
  9. Br J Cancer. 2008 Feb 12;98(3):580-6 - PubMed
  10. Proc Natl Acad Sci U S A. 1979 May;76(5):2438-41 - PubMed
  11. Med Clin North Am. 2014 Jan;98(1):39-54 - PubMed
  12. J Neurosci Res. 2006 Aug 15;84(3):578-86 - PubMed
  13. Gastroenterology. 1992 Jun;102(6):2108-13 - PubMed
  14. Virus Res. 2008 May;133(2):167-77 - PubMed
  15. Hepatology. 2002 Jan;35(1):217-23 - PubMed
  16. Intervirology. 2009;52(5):239-46 - PubMed
  17. Gastroenterology. 2011 May;140(5):1490-500.e3 - PubMed
  18. Free Radic Biol Med. 2013 Dec;65:632-44 - PubMed
  19. J Gerontol A Biol Sci Med Sci. 2008 May;63(5):505-9 - PubMed
  20. Virol J. 2010 Sep 14;7:228 - PubMed
  21. PLoS One. 2012;7(5):e36818 - PubMed
  22. Dig Dis Sci. 2013 May;58(5):1355-62 - PubMed
  23. J Viral Hepat. 2012 Feb;19(2):e170-6 - PubMed
  24. J Infect Dis. 1999 Nov;180(5):1452-8 - PubMed
  25. Indian J Gastroenterol. 2014 Jan;33(1):12-8 - PubMed
  26. Hepat Mon. 2013 Oct 05;13(10):e13136 - PubMed
  27. Eur J Gastroenterol Hepatol. 2015 Feb;27(2):130-6 - PubMed
  28. Mutat Res. 2010 Jan 5;683(1-2):23-8 - PubMed
  29. Middle East J Dig Dis. 2014 Oct;6(4):186-94 - PubMed
  30. J Med Virol. 2011 Apr;83(4):594-601 - PubMed
  31. Biol Blood Marrow Transplant. 2014 Dec;20(12):1912-7 - PubMed
  32. Liver Transpl. 2010 Nov;16(11):1303-13 - PubMed
  33. Hepatol Res. 2013 Dec;43(12):1276-83 - PubMed
  34. Free Radic Biol Med. 2007 Aug 15;43(4):477-503 - PubMed
  35. Cancer Res. 2006 Oct 15;66(20):9845-51 - PubMed

Publication Types